Abatacept and certolizumab pegol shows better clinical remission rates than active conventional therapy for RA
Study explores the role of herbs and spices as adjuvant therapies in enhancing patient outcomes in the management of rheumatic disease
Peresolimab, a humanized IgG1 monoclonal antibody treatment for rheumatoid arthritis, shows promising results in phase 2a trial
ASCORE study reports improved abatacept retention and clinical response rates in patients who received early subcutaneous abatacept
